J 2021

ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings

FAROLFI, Martina, Anna CECHOVA, Nina ONDRUSKOVA, Jana ZÍDKOVÁ, Bohdan KOUSAL et. al.

Základní údaje

Originální název

ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings

Autoři

FAROLFI, Martina (203 Česká republika), Anna CECHOVA (203 Česká republika), Nina ONDRUSKOVA (203 Česká republika), Jana ZÍDKOVÁ (203 Česká republika, domácí), Bohdan KOUSAL (203 Česká republika), Hana HANSIKOVA (203 Česká republika), Tomas HONZIK (203 Česká republika) a Petra LISKOVA (203 Česká republika)

Vydání

BMC OPHTHALMOLOGY, LONDON, BMC, 2021, 1471-2415

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30207 Ophthalmology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.086

Kód RIV

RIV/00216224:14110/21:00123482

Organizační jednotka

Lékařská fakulta

UT WoS

000660890800001

Klíčová slova anglicky

N-linked glycosylation; Congenital disorder of glycosylation; ALG3-CDG; Optic nerve hypoplasia; Arthrogryposis; Transferrin isoelectric focusing; Novel mutation

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 4. 1. 2022 13:41, Mgr. Tereza Miškechová

Anotace

V originále

BackgroundALG3-CDG is a rare autosomal recessive disease. It is characterized by deficiency of alpha-1,3-mannosyltransferase caused by pathogenic variants in the ALG3 gene. Patients manifest with severe neurologic, cardiac, musculoskeletal and ophthalmic phenotype in combination with dysmorphic features, and almost half of them die before or during the neonatal period.Case presentationA 23 months-old girl presented with severe developmental delay, epilepsy, cortical atrophy, cerebellar vermis hypoplasia and ocular impairment. Facial dysmorphism, clubfeet and multiple joint contractures were observed already at birth. Transferrin isoelectric focusing revealed a type 1 pattern. Funduscopy showed hypopigmentation and optic disc pallor. Profound retinal ganglion cell loss and inner retinal layer thinning was documented on spectral-domain optical coherence tomography imaging. The presence of optic nerve hypoplasia was also supported by magnetic resonance imaging. A gene panel based next-generation sequencing and subsequent Sanger sequencing identified compound heterozygosity for two novel variants c.116del p.(Pro39Argfs*40) and c.1060 C>T p.(Arg354Cys) in ALG3.ConclusionsOur study expands the spectrum of pathogenic variants identified in ALG3. Thirty-three variants in 43 subjects with ALG3-CDG have been reported. Literature review shows that visual impairment in ALG3-CDG is most commonly linked to optic nerve hypoplasia.